ADAR1 Capital Management, LLC - 24 Apr 2025 SCHEDULE 13D/A Report for Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

Filing Manager
ADAR1 Capital Management, LLC
Reporting Manager
ADAR1 Capital Management, LLC
Security
Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KROS
Shares outstanding
40,564,063 shares
Disclosed Ownership
5,390,964 shares
Ownership
13.3%
Form type
SCHEDULE 13D/A
Filing time
28 Apr 2025, 18:43:57 UTC
Date of event
24 Apr 2025
Previous filing
11 Apr 2025
Next filing
08 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 13.29% 5,390,964 5,390,964 0 /s/ Daniel Schneeberger Daniel Schneeberger, Manager 0001940272
ADAR1 Capital Management GP, LLC 11.46% 4,647,406 4,647,406 0 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
Daniel Schneeberger 13.29% 5,390,964 5,390,964 0 /s/ Daniel Schneeberger Daniel Schneeberger